Pneumocystis

Manual of Clinical Microbiology: Tenth Edition

Volumn 2-2, Issue , 2022, Pages 1822-1835

  Cushion, Melanie T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Immunofluorescent assay (IFA); PCR; Pneumocystis; Serologic tests; Trimethoprim sulfamethoxazole (TMP SMX)

Indexed keywords

EID: 84900316005     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1128/9781555816728.ch116     Document Type: Chapter

References (107)

1. Alvarez-Martinez, M. J., J. M. Miro, M. E. Valls, A. Moreno, P. V. Rivas, M. Sole, N. Benito, P. Domingo, C. Munoz, E. Rivera, H. J. Zar, G. Wissmann, A. R. Diehl, J. C. Prolla, M. T. de Anta, J. M. Gatell, P. E. Wilson, S. R. Meshnick, and Spanish PCP Working Group. 2006. Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn. Microbiol,. Infect. Dis. 56:153-160.
2. Atochina-Vasserman, E. N., A. J. Gow, H. Abramova, C. J. Guo, Y. Tomer, A. M. Preston, J. M. Beck, and M. F. Beers. 2009. Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation. J. Immunol. 182:2277-2287.
3. Baughman, R. P. 1994. Use of bronchoscopy in the diagnosis of infection in the immunocompromised host. Thorax 49:3-7.
4. Beard, C. B., J. L. Carter, S. P. Keely, L. Huang, N. J. Pieniazek, I. N. Moura, J. M. Roberts, A. W. Hightower, M. S. Bens, A. R. Freeman, S. Lee, J. R. Stringer, J. S. Duchin, C. Del Rio, D. Rimland, R. P. Baughman, D. A. Levy, V. J. Dietz, P. Simon, and T. R. Navin. 2000. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg. Infect. Dis. 6:265-272.
5. Bell, C. A., C. C. Dykstra, N. A. Naiman, M. Cory, T. A. Fairley, and R. R. Tidwell. 1993. Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition. Antimicrob. Agents Chemother. 37:2668-2673.
6. Birriel, J. A., Jr., J. A. Adams, M. A. Saldana, K. Mavunda, S. Goldfinger, D. Vernon, B. Holzman, and R. M. McKey, Jr. 1991. Role of flexible bronchoscopy and bronchoalveolar lavage in the diagnosis of pediatric acquired immunodeficiency syndrome-related pulmonary disease. Pediatrics 87:897-899.
7. Campbell, W. G., Jr. 1972. Ultrastructure of Pneumocystis in human lung. Life cycle in human pneumocystosis. Arch. Pathol. 93:312-324.
8. Chandler, F. W., Jr., J. K. Frenkel, and W. G. Campbell, Jr. 1979. Pneumocystis pneumonia. Animal model: Pneumocystis carinii pneumonia in the immunosuppressed rat. Am. J. Pathol. 95:571-574.
9. Chandra, P., M. D. Delaney, and C. U. Tuazon. 1988. Role of special stains in the diagnosis of Pneumocystis carinii infection from bronchial washing specimens in patients with the acquired immune deficiency syndrome. Acta Cytol. 32:105-108.
10. Cushion, M. T. 2004. Pneumocystis: unraveling the cloak of obscurity. Trends Microbiol. 12:243-249.
11. Cushion, M. T., F. Chen, and N. Kloepfer. 1997. A cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents. Antimicrob. Agents Chemother. 41:379-384.
12. Cushion, M. T., M. S. Collins, and M. J. Linke. 2009. Biofilm formation by Pneumocystis spp. Eukaryot. Cell 8:197-206.
13. Cushion, M. T., M. Kaselis, S. L. Stringer, and J. R. Stringer. 1993. Genetic stability and diversity of Pneumocystis carinii infecting rat colonies. Infect. Immun. 61:4801-4813.
14. Cushion, M. T., S. P. Keely, and J. R. Stringer. 2005. Validation of the name Pneumocystis wakefieldiae. Mycologia 97:268.
15. Cushion, M. T., M. J. Linke, A. Ashbaugh, T. Sesterhenn, M. S. Collins, K. Lynch, R. Brubaker, and P. D. Walzer. 2010. Echinocandin treatment of Pneumocystis pneumonia in rodent models depletes cysts leaving significant trophic burdens that cannot transmit the infection. PLoS ONE 5:e8524.
16. Cushion, M. T., M. J. Linke, M. Collins, S. P. Keely, and J. R. Stringer. 1999. The minimum number of Pneumocystis carinii f. sp. carinii organisms required to establish infections is very low. J. Eukaryot. Microbiol. 46:111S.
17. Cushion, M. T., J. J. Ruffolo, M. J. Linke, and P. D. Walzer. 1985. Pneumocystis carinii: growth variables and estimates in the A549 and WI-38 VA13 human cell lines. Exp. Parasitol. 60:43-54.
18. Cushion, M. T., J. J. Ruffolo, and P. D. Walzer. 1988. Analysis of the developmental stages of Pneumocystis carinii, in vitro. Lab. Investig. 58:324-331.
19. Cushion, M. T., A. G. Smulian, B. E. Slaven, T. Sesterhenn, J. Arnold, C. Staben, A. Porollo, R. Adamczak, and J. Meller. 2007. Transcriptome of Pneumocystis carinii during fulminate infection: carbohydrate metabolism and the concept of a compatible parasite. PLoS ONE 2:e423.
20. Dei-Cas, E., M. Chabe, R. Moukhlis, I. Durand-Joly, e. M. Aliouat, J. R. Stringer, M. Cushion, C. Noel, G. S. de Hoog, J. Guillot, and E. Viscogliosi. 2006. Pneumocystis oryctolagi sp. nov., an uncultured fungus causing pneumonia in rabbits at weaning: review of current knowledge, and description of a new taxon on genotypic, phylogenetic and phenotypic bases. FEMS Microbiol. Rev. 30:853-871.
21. De Stefano, J. A., M. T. Cushion, R. G. Sleight, and P. D. Walzer. 1990. Analysis of Pneumocystis carinii cyst wall. I. Evidence for an outer surface membrane. J. Protozool. 37:428-435.
22. Droste, A., G. Grosse, and F. Niedobitek. 1991. Extrapul- monary manifestations of Pneumocystis carinii infection in AIDS. Verh. Dtsch. Ges. Pathol. 75:158-162. (In German.)
23. Dumoulin, A., E. Mazars, N. Seguy, D. Gargallo-Viola, S. Vargas, J. C. Cailliez, E. M. Aliouat, A. E. Wakefield, and E. Dei-Cas. 2000. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur. J. Clin. Microbiol. Infect. Dis. 19:671-678.
24. Durand-Joly, I., M. Chabe, F. Soula, L. Delhaes, D. Camus, and E. Dei-Cas. 2005. Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol. Med. Microbiol. 45:405-410.
25. Edman, J. C., J. A. Kovacs, H. Masur, D. V. Santi, H. J. Elwood, and M. L. Sogin. 1988. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519-522.
26. Elvin, K., and E. Linder. 1993. Application and staining patterns of commercial anti-Pneumocystis carinii monoclonal antibodies. J. Clin. Microbiol. 31:2222-2224.
27. Esteves, F., M. A. Montes-Cano, C. de la Horra, M. C. Costa, E. J. Calderon, F. Antunes, and O. Matos. 2008. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin. Microbiol. Infect. 14:356-362.
28. Etoh, K. 2008. Evaluation of a real-time PCR assay for the diagnosis of Pneumocystis pneumonia. Kurume Med. J. 55:55-62.
29. Fatti, G. L., H. J. Zar, and G. H. Swingler. 2006. Clinical indicators of Pneumocystis jiroveci pneumonia (PCP) in South African children infected with the human immunodeficiency virus. Int. J. Infect. Dis. 10:282-285.
30. Fillaux, J., S. Malvy, M. Alvarez, R. Fabre, S. Cassaing, B. Marchou, M. D. Linas, and A. Berry. 2008. Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. J. Microbiol. Methods 75:258-261.
31. Fisk, D. T., S. Meshnick, and P. H. Kazanjian. 2003. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin. Infect. Dis. 36:70-78.
32. Fisk, M., E. K. Sage, S. G. Edwards, J. D. Cartledge, and R. F. Miller. 2009. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole. Int. J. STD AIDS 20:652-653.
33. Frenkel, J. K. 1976. Pneumocystis jiroveci n. sp. from man: morphology, physiology, and immunology in relation to pathology. Natl. Cancer Inst. Monogr. 43:13-30.
34. Frenkel, J. K. 1999. Pneumocystis pneumonia, an immunodeficiency-dependent disease (IDD): a critical historical overview. J. Eukaryot. Microbiol. 46:89S-92S.
35. Gajdusek, D. C. 1957. Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 19:543-565.
36. Hadley, W. K., and V. L. Ng. 1999. Pneumocystis, p. 1200-1211. In P. M. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of Clinical Microbiology, 7th ed. ASM Press, Washington, DC.
37. Hawksworth, D. L. 2007. Responsibility in naming pathogens: the case of Pneumocystis jirovecii, the causal agent of pneumocystis pneumonia. Lancet Infect. Dis. 7:3-5.
38. Hibbett, D. S., M. Binder, J. F. Bischoff, M. Blackwell, P. F. Cannon, O. E. Eriksson, S. Huhndorf, T. James, P. M. Kirk, R. Lucking, L. H. Thorsten, F. Lutzoni, P. B. Matheny, D. J. McLaughlin, M. J. Powell, S. Redhead, C. L. Schoch, J. W. Spatafora, J. A. Stalpers, R. Vilgalys, M. C. Aime, A. Aptroot, R. Bauer, D. Begerow, G. L. Benny, L. A. Castlebury, P. W. Crous, Y. C. Dai, W. Gams, D. M. Geiser, G. W. Griffith, C. Gueidan, D. L. Hawksworth, G. Hestmark, K. Hosaka, R. A. Humber, K. D. Hyde, J. E. Ironside, U. Koljalg, C. P. Kurtzman, K. H. Larsson, R. Lichtwardt, J. Longcore, J. Miadlikowska, A. Miller, J. M. Moncalvo, S. Mozley-Standridge, F. Oberwinkler, E. Parmasto, V. Reeb, J. D. Rogers, C. Roux, L. Ryvarden, J. P. Sampaio, A. Schussler, J. Sugiyama, R. G. Thorn, L. Tibell, W. A. Untereiner, C. Walker, Z. Wang, A. Weir, M. Weiss, M. M. White, K. Winka, Y. J. Yao, and N. Zhang. 2007. A higher-level phylogenetic classification of the Fungi. Mycol. Res. 111:509-547.
39. Huang, L. 2005. Clinical presentation and diagnosis of Pneumocystis pneumonia in HIV-infected patients, p. 349-406. In P. D. Walzer and M. T. Cushion (ed.), Pneumocystis Pneumonia. Marcel-Dekker, New York, NY.
40. Huang, L., and K. Crothers. 2009. HIV-associated opportunistic pneumonias. Respirology 14:474-485.
41. Huang, L., F. M. Hecht, J. D. Stansell, R. Montanti, W. K. Hadley, and P. C. Hopewell. 1995. Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful? Am. J. Respir. Crit. Care Med. 151:1866-1871.
42. Huggett, J. F., M. S. Taylor, G. Kocjan, H. E. Evans, S. Morris-Jones, V. Gant, T. Novak, A. M. Costello, A. Zumla, and R. F. Miller. 2008. Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients. Thorax 63:154-159.
43. Hughes, W. T. 1982. Natural mode of acquisition for de novo infection with Pneumocystis carinii. J. Infect. Dis. 145:842-848.
44. Icenhour, C. R., S. L. Rebholz, M. S. Collins, and M. T. Cushion. 2001. Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J. Clin. Microbiol. 39:3437-3441.
45. Icenhour, C. R., S. L. Rebholz, M. S. Collins, and M. T. Cushion. 2002. Early acquisition of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral swabs. Eukaryot. Cell 1:414-419.
46. Jarboui, M. A., A. Sellami, H. Sellami, F. Cheikhrouhou, F. Makni, N. Ben Arab, M. Ben Jemaa, and A. Ayadi. 2010. Molecular diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Mycoses 53:329-333.
47. Kamboj, M., D. Weinstock, and K. A. Sepkowitz. 2006. Progression of Pneumocystis jiroveci pneumonia in patients receiving echinocandin therapy. Clin. Infect. Dis. 43:e92-e94.
48. Kauffman, C. A., and P. L. Carver. 2008. Update on echinocandin antifungals. Semin. Respir. Crit. Care Med. 29:211-219.
49. Kaur, N., and T. C. Mahl. 2007. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig. Dis. Sci. 52:1481-1484.
50. Kazanjian, P., W. Armstrong, P. A. Hossler, C. H. Lee, L. Huang, C. B. Beard, J. Carter, L. Crane, J. Duchin, W. Burman, J. Richardson, and S. R. Meshnick. 2001. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. J. Infect. Dis. 183:819-822.
51. Keely, S. P., J. M. Fischer, M. T. Cushion, and J. R. Stringer. 2004. Phylogenetic identification of Pneumocystis murina sp. nov., a new species in laboratory mice. Microbiology 150:1153-1165.
52. Keely, S. P., and J. R. Stringer. 2009. Complexity of the MSG gene family of Pneumocystis carinii. BMC Genomics 10:367.
53. Komano, Y., M. Harigai, R. Koike, H. Sugiyama, J. Ogawa, K. Saito, N. Sekiguchi, M. Inoo, I. Onishi, H. Ohashi, F. Amamoto, M. Miyata, H. Ohtsubo, K. Hiramatsu, M. Iwamoto, S. Minota, N. Matsuoka, G. Kageyama, K. Imaizumi, H. Tokuda, Y. Okochi, K. Kudo, Y. Tanaka, T. Takeuchi, and N. Miyasaka. 2009. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. Arthritis Rheum. 61:305-312.
54. Kovacs, J. A., V. J. Gill, S. Meshnick, and H. Masur. 2001. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 286:2450-2460.
55. Lane, B. R., J. C. Ast, P. A. Hossler, D. P. Mindell, M. S. Bartlett, J. W. Smith, and S. R. Meshnick. 1997. Dihy- dropteroate synthase polymorphisms in Pneumocystis carinii. J. Infect. Dis. 175:482-485.
56. Lee, C. H., J. Helweg-Larsen, X. Tang, S. Jin, B. Li, M. S. Bartlett, J. J. Lu, B. Lundgren, J. D. Lundgren, M. Olsson, S. B. Lucas, P. Roux, A. Cargnel, C. Atzori, O. Matos, and J. W. Smith. 1998. Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J. Clin. Microbiol. 36:734-741.
57. Limper, A. H., S. T. Pottratz, and W. J. Martin. 1991. Modulation of Pneumocystis carinii adherence to cultured lung cells by a mannose-dependent mechanism. J. Lab. Clin. Med. 118:492-499.
58. Madhi, S. A., C. Cutland, K. Ismail, C. O'Reilly, A. Mancha, and K. P. Klugman. 2002. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Clin. Infect. Dis. 35:1120-1126.
59. Mahan, C. T., and G. E. Sale. 1978. Rapid methenamine silver stain for Pneumocystis and fungi. Arch. Pathol. Lab. Med. 102:351-352.
60. Matsumoto, Y., and Y. Yoshida. 1984. Sporogony in Pneumocystis carinii: synaptonemal complexes and meiotic nuclear divisions observed in precysts. J. Protozool. 31:420-428.
61. Medrano, F. J., M. Montes-Cano, M. Conde, C. de la Horra, N. Respaldiza, A. Gasch, M. J. Perez-Lozano, J. M. Varela, and E. J. Calderon. 2005. Pneumocystis jirovecii in general population. Emerg. Infect. Dis. 11:245-250.
62. Miller, R. F., A. R. Lindley, A. Copas, H. E. Ambrose, R. J. Davies, and A. E. Wakefield. 2005. Genotypic variation in Pneumocystis jirovecii isolates in Britain. Thorax 60:679-682.
63. Mofenson, L. M., M. T. Brady, S. P. Danner, K. L. Dominguez, R. Hazra, E. Handelsman, P. Havens, S. Nesheim, J. S. Read, L. Serchuck, R. Van Dyke, Centers for Disease Control and Prevention, National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and American Academy of Pediatrics. 2009. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm. Rep. 58:1-166.
64. Monnet, X., E. Vidal-Petiot, D. Osman, O. Hamzaoui, A. Durrbach, C. Goujard, C. Miceli, P. Bouree, and C. Richard. 2008. Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit. Care 12:R28.
65. Mori, S., I. Cho, H. Ichiyasu, and M. Sugimoto. 2008. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Mod. Rheumatol. 18:240-246.
66. Mori, S., I. Cho, and M. Sugimoto. 2009. A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis. J. Rheumatol. 36:1600-1605.
67. Morris, A. 2008. Is there anything new in Pneumocystis jirovecii pneumonia? Changes in P. jirovecii pneumonia over the course of the AIDS epidemic. Clin. Infect. Dis. 46:634-636.
68. Morris, A., J. D. Lundgren, H. Masur, P. D. Walzer, D. L. Hanson, T. Frederick, L. Huang, C. B. Beard, and J. E. Kaplan. 2004. Current epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis. 10:1713-1720.
69. Morris, A., M. Netravali, H. M. Kling, T. Shipley, T. Ross, F. C. Sciurba, and K. A. Norris. 2008. Relationship of pneumocystis antibody response to severity of chronic obstructive pulmonary disease. Clin. Infect. Dis. 47:e64-e68.
70. Morris, A., F. C. Sciurba, I. P. Lebedeva, A. Githaiga, W. M. Elliott, J. C. Hogg, L. Huang, and K. A. Norris. 2004. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am. J. Respir. Crit. Care Med. 170:408-413.
71. Morris, A., F. C. Sciurba, and K. A. Norris. 2008. Pneumocystis: a novel pathogen in chronic obstructive pulmonary disease? COPD 5:43-51.
72. Ng, V. L., I. Gartner, L. A. Weymouth, C. D. Goodman, P. C. Hopewell, and W. K. Hadley. 1989. The use of mucolysed induced sputum for the identification of pulmonary pathogens associated with human immunodeficiency virus infection. Arch. Pathol. Lab. Med. 113:488-493.
73. Ng, V. L., D. M. Yajko, and W. K. Hadley. 1997. Extrapul- monary pneumocystosis. Clin. Microbiol. Rev. 10:401-418.
74. Patel, N., and H. Koziel. 2004. Pneumocystis jiroveci pneumonia in adult patients with AIDS: treatment strategies and emerging challenges to antimicrobial therapy. Treat. Respir. Med. 3:381-397.
75. Peglow, S. L., A. G. Smulian, M. J. Linke, C. L. Pogue, S. Nurre, J. Crisler, J. Phair, J. W. Gold, D. Armstrong, and P. D. Walzer. 1990. Serologic responses to Pneumocystis carinii antigens in health and disease. J. Infect. Dis. 161:296-306.
76. Peterson, J. C., and M. T. Cushion. 2005. Pneumocystis: not just pneumonia. Curr. Opin. Microbiol. 8:393-398.
77. Pottratz, S. T. 1998. Pneumocystis carinii interactions with respiratory epithelium. Semin. Respir. Infect. 13:323-329.
78. Pottratz, S. T., and W. J. Martin. 1990. Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J. Clin. Investig. 85:351-356.
79. Pottratz, S. T., J. Paulsrud, J. S. Smith, and W. J. Martin. 1991. Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J. Clin. Investig. 88:403-407.
80. Qu, J., L. He, Z. Rong, J. Pan, X. Chen, D. C. Morrison, and X. Li. 2001. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia. Chin. Med. J. 114:1143-1146.
81. Radhi, S., T. Alexander, M. Ukwu, S. Saleh, and A. Morris. 2008. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003. BMC Infect. Dis. 8:118.
82. Rebholz, S. L., and M. T. Cushion. 2001. Three new karyotype forms of Pneumocystis carinii f. sp. carinii identified by contoured clamped homogeneous electrical field (CHEF) electrophoresis. J. Eukaryot. Microbiol. 2001(Suppl.):109S-110S.
83. Redhead, S. A., M. T. Cushion, J. K. Frenkel, and J. R. Stringer. 2006. Pneumocystis and Trypanosoma cruzi: nomenclature and typifications. J. Eukaryot. Microbiol. 53:2-11.
84. Schmidt, R., P. Markart, C. Ruppert, B. Temmesfeld, R. Nass, J. Lohmeyer, W. Seeger, and A. Gunther. 2006. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome. Crit. Care Med. 34:2370-2376.
85. Schumann, G. B., and J. J. Swensen. 1991. Comparison of Papanicolaou's stain with the Gomori methenamine silver (GMS) stain for the cytodiagnosis of Pneumocystis carinii in bronchoalveolar lavage (BAL) fluid. Am. J. Clin. Pathol. 95:583-586.
86. Smulian, A. G., T. Sesterhenn, R. Tanaka, and M. T. Cushion. 2001. The ste3 pheromone receptor gene of Pneumocystis carinii is surrounded by a cluster of signal transduction genes. Genetics 157:991-1002.
87. Soulez, B., F. Palluault, J. Y. Cesbron, E. Dei-Cas, A. Capron, and D. Camus. 1991. Introduction of Pneumocystis carinii in a colony of SCID mice. J. Protozool. 38:123S-125S.
88. Spencer, L., M. Ukwu, T. Alexander, K. Valadez, L. Liu, T. Frederick, A. Kovacs, and A. Morris. 2008. Epidemiology of Pneumocystis colonization in families. Clin. Infect. Dis. 46:1237-1240.
89. Stagno, S., L. L. Pifer, W. T. Hughes, D. M. Brasfield, and R. E. Tiller. 1980. Pneumocystis carinii pneumonitis in young immunocompetent infants. Pediatrics 66:56-62.
90. Stringer, J. R., J. C. Edman, M. T. Cushion, F. F. Richards, and J. Watanabe. 1992. The fungal nature of Pneumocystis. J. Med. Vet. Mycol. 30(Suppl. 1):271-278.
91. Strutt, M., and M. Smith. 2005. Development of a real-time probe-based PCR assay for the diagnosis of Pneumocystis pneumonia. Med. Mycol. 43:343-347.
92. Sun, L., M. J. Huang, Y. J. An, and Z. Z. Guo. 2009. An epidemiologic study on Pneumocystis pneumonia in nonHIV infected patients in China. Zhonghua Liu Xing Bing Xue Za Zhi 30:348-351.
93. Teichmann, L. L., M. Woenckhaus, C. Vogel, B. Salzberger, J. Scholmerich, and M. Fleck. 2008. Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. Rheumatology (Oxford) 47:1256-1257.
94. Tellez, I., M. Barragan, C. Franco-Paredes, P. Petraro, K. Nelson, and C. Del Rio. 2008. Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city: a persistent and deadly opportunistic infection. Am. J. Med. Sci. 335:192-197.
95. Telzak, E. E., R. J. Cote, J. W. Gold, S. W. Campbell, and D. Armstrong. 1990. Extrapulmonary Pneumocystis carinii infections. Rev. Infect. Dis. 12:380-386.
96. Thomas, C. F., Jr., and A. H. Limper. 2007. Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat. Rev. Microbiol. 5:298-308.
97. Tsolaki, A. G., R. F. Miller, and A. E. Wakefield. 1999. Oropharyngeal samples for genotyping and monitoring response to treatment in AIDS patients with Pneumocystis carinii pneumonia. J. Med. Microbiol. 48:897-905.
98. Vargas, S. L., W. T. Hughes, M. E. Santolaya, A. V. Ulloa, C. A. Ponce, C. E. Cabrera, F. Cumsille, and F. Gigliotti. 2001. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin. Infect. Dis. 32:855-861.
99. Vargas, S. L., C. A. Ponce, F. Gigliotti, A. V. Ulloa, S. Prieto, M. P. Munoz, and W. T. Hughes. 2000. Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J. Clin. Microbiol. 38:1536-1538.
100. Vohra, P. K., J. G. Park, B. Sanyal, and C. F. Thomas, Jr. 2004. Expression analysis of PCSTE3, a putative pheromone receptor from the lung pathogenic fungus Pneumocystis carinii. Biochem. Biophys. Res. Commun. 319:193-199.
101. Wakefield, A. E., F. J. Pixley, S. Banerji, K. Sinclair, R. F. Miller, E. R. Moxon, and J. M. Hopkin. 1990. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol. Biochem. Parasitol. 43:69-76.
102. Walzer, P. D., K. Djawe, L. Levin, K. R. Daly, J. Koch, L. Kingsley, M. Witt, E. T. Golub, J. H. Bream, B. Taiwo, and A. Morris. 2009. Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection. J. Infect. Dis. 199:1335-1344.
103. Walzer, P. D., H. E. Evans, A. J. Copas, S. G. Edwards, A. D. Grant, and R. F. Miller. 2008. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin. Infect. Dis. 46:625-633.
104. Walzer, P. D., V. Schnelle, D. Armstrong, and P. P. Rosen. 1977. Nude mouse: a new experimental model for Pneumocystis carinii infection. Science 197:177-179.
105. Walzer, P. D., and A. G. Smulian. 2010. Pneumocystis species, p. 3377-3390. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Churchill Livingstone Elsevier, Philadelphia, PA.
106. Waters, L., and M. Nelson. 2007. The use of caspofungin in HIV-infected individuals. Expert Opin. Investig. Drugs 16:899-908.
107. Yazaki, H., N. Goto, K. Uchida, T. Kobayashi, H. Gatanaga, and S. Oka. 2009. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host. Transplantation 88:380-385.